Printed from Voxsanity (voxsanity.com.au) — NCT07387094 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Sleep Disorders
Phase 3 Sleep Disorders Trial, Recruiting
NCT07387094
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a Body Mass Index (BMI) of 28 or higher (a measure of body weight relative to height)
- People who have had a sleep study that confirms a diagnosis of obstructive sleep apnea (OSA), with a moderate-to-severe level of breathing interruptions during sleep (an AHI score of 15 or more)
- People who have not used a PAP machine (a breathing device worn during sleep, such as a CPAP) for at least 4 weeks before the screening visit, and who would not use one during the study
- People who have tried at least one diet in the past to lose weight without lasting success (self-reported)
Who may not be able to join:
- People with a history of hormonal or gland-related conditions (such as thyroid disorders) that significantly affect body weight
- People who have been diagnosed with diabetes (other than diabetes during pregnancy), or who have had a dangerous blood sugar crisis
- People whose blood sugar control measure (HbA1c) is 6.5% or higher at the screening visit
- People whose fasting blood sugar or blood sugar after a sugar drink test is above certain levels at screening (confirm with trial site for exact numbers and testing requirements)
- People diagnosed with a specific breathing pattern during sleep called Cheyne Stokes Respiration, or whose sleep apnea is mainly caused by brain signals rather than airway blockage (central or mixed sleep apnea making up 50% or more of events)
- People with lung or nerve/muscle conditions that could affect the trial results
- People diagnosed with Obesity Hypoventilation Syndrome or who have too much carbon dioxide in their blood during the day
- People whose body weight has changed by more than 5% in the 3 months before screening (self-reported)
- People who have had, or are planning, surgery for weight loss (unless a liposuction or tummy tuck procedure was performed more than 1 year before screening)
- People who have taken any medication for weight loss, blood sugar lowering, or medication known to cause significant weight gain, within the 3 months before screening
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 3
Sponsor
Hangzhou Sciwind Biosciences Co., Ltd.
Registry
ClinicalTrials.gov
Start date
9 February 2026
Est. completion
16 December 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Change from baseline in Apnea-Hypopnea Index (AHI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.